VistaGen Therapeutics, Inc. (20)

Browse by Contract Category

Contracts

Agreement and Plan of Merger, by and among Vistagen Therapeutics, Inc., VTGN Merger Sub, Inc., Pherin Pharmaceuticals, Inc., and Kevin McCarthy, dated December 20, 2022 (Filed With SEC on December 21, 2022)
Consulting Agreement between Vistagen Therapeutics, Inc and i3 Strategy, dated November 10, 2022 (Filed With SEC on November 10, 2022)
Indemnification Agreement, dated May 13, 2022, by and between VistaGen Therapeutics, Inc. and Reid G. Adler J.D (Filed With SEC on August 11, 2022)
Third Amendment to Lease, by and between Bayside Area Development, LLC and VistaGen Therapeutics, Inc. dated October 14, 2021 (Filed With SEC on November 10, 2021)
Open Market Sale AgreementSM, dated May 14, 2021, by and between VistaGen Therapeutics, Inc. and Jefferies LLC (Filed With SEC on May 14, 2021)
Underwriting Agreement, dated December 18, 2020, by and among VistaGen Therapeutics, Inc., Jefferies LLC and William Blair & Company, L.L.C (Filed With SEC on December 22, 2020)
Amendment No, 1 to Consulting Services Agreement between Vistagen Therapeutics, Inc and FitzPatrick & Co. LLC, effective June 1, 2022 (Filed With SEC on November 10, 2022)
Consulting Services Agreement between Vistagen Therapeutics, Inc and FitzPatrick & Co. LLC, dated January 21, 2022 (Filed With SEC on November 10, 2022)
Indemnification Agreement, dated July 21, 2021, by and between VistaGen Therapeutics, Inc. and Margaret M. FitzPatrick (Filed With SEC on July 22, 2021)
Indemnification Agreement, dated July 6, 2021, by and between VistaGen Therapeutics, Inc. and Mary L. Rotunno J.D (Filed With SEC on July 8, 2021)
License and Collaboration Agreement, by and between VistaGen Therapeutics, Inc. and EverInsight Therapeutics Inc., dated June 24, 2020 (Filed With SEC on August 13, 2020)
Underwriting Agreement, dated August 2, 2020, by and between VistaGen Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on August 6, 2020)
License and Collaboration Agreement, by and between VistaGen Therapeutics, Inc. and EverInsight Therapeutics Inc., dated June 24, 2020 (Filed With SEC on June 26, 2020)
Form of Warrant (Filed With SEC on January 27, 2020)
Form of Securities Purchase Agreement, dated January 24, 2020, between the Company and each purchaser named in the signature pages thereto (Filed With SEC on January 27, 2020)
Form of Subscription Agreement for Fall 2019 Private Placement (Filed With SEC on November 7, 2019)
Master Services Agreement, dated July 11, 2017, by and between VistaGen Therapeutics, Inc. and Cato Research Ltd (Filed With SEC on June 25, 2019)
Indemnification Agreement, dated November 10, 2016, by and between VistaGen Therapeutics, Inc. and Mark A. McPartland (Filed With SEC on June 25, 2019)
Underwriting Agreement, dated February 26, 2019, by and between VistaGen Therapeutics, Inc. and William Blair & Company, L.L.C (Filed With SEC on March 4, 2019)
Indemnification Agreement, dated January 10, 2019, by and between VistaGen Therapeutics, Inc. and Ann Cunningham (Filed With SEC on January 15, 2019)